Pfizer: This Blue Chip DGI Name Strengthens Its Pipeline With Array BioPharma

Summary

  • Pfizer is generally a fairly boring company.
  • PFE shares offer a 3.4% dividend yield and relatively low volatility.
  • On Monday, PFE management inked a $11.4b M&A deal that should bolster its already impressive pipeline.
  • This idea was discussed in more depth with members of my private investing community, The Dividend Growth Club . Start your free trial today »

Pfizer (PFE) is an interesting company to follow in the DGI world. Frankly put, it’s a name that people love to hate. The company reached highs of ~$48/share during the top of the dot-com boom in the year 2000 and was seemingly all the rage with a P/E multiple in the 50x range. However, this elevated multiple was just too much for the company's stock to overcome and even though its bottom-line growth wasn’t bad, PFE shares spent basically the entirety of the 2000-2010 decade in a constant downfall. At the trough of the Great Recession in 2009, PFE shares were trading for just 5x earnings. They fell from nearly $50/share to just $12/share. It’s 2019 and Pfizer still hasn’t reclaimed that 2000-high. This leads many investors to believe that this stock has been dead money for the last 20 years and therefore, a terrible investment; however, I beg to differ.

While PFE’s share price might not be higher than it was in 2000, its EPS has tripled since then. They were $1.02 in 2000 and $3.00 in 2018. Since the turn of the millennia, PFE has generated positive bottom-line growth in 15 of the 19 years. This is pretty consistent, especially when considering the fact that we’ve experienced two major recessions during that time frame. 9 out of those 15 positive years were double-digit EPS growth years and just 1 of the negative years (2009) was a double-digit negative growth year. EPS was down 10% in 2009 and during that year the company cut its quarterly dividend in half, from $0.32/share to $0.16/share as well. This dividend cut added to the sour taste that the 2000s had left in PFE investors’ mouths. However, since then, the company has begun a new annual dividend increase streak and the current dividend is back above the 2008 levels, at $0.36/share.

READ FULL ARTICLE HERE